Results 211 to 220 of about 23,125,138 (369)
Role of high-dose interleukin-2 for melanoma in the age of cellular therapy. [PDF]
Buchbinder E +13 more
europepmc +1 more source
Sialic Acid Sensing via Molecularly Imprinted Polymer on Laser‐Induced Graphene
Sialic acid is an important biomarker for oral and overall health. Salivary levels of sialic acid are linked with oral cancer and other diseases. We develop a point‐of‐care sensor for sialic acid, based on molecularly imprinted aminophenylboronic acid electropolymerized onto laser‐induced graphene.
Alexander V. Shokurov +2 more
wiley +1 more source
Monoclonal antibodies against the Crohn´s disease - involved pancreatic autoantigen [PDF]
Horbach, E. +5 more
core +1 more source
Myositis associated with interleukin-2 therapy in a patient with metastatic renal cell carcinoma [PDF]
Francisco J. Esteva-Lorenzo +5 more
openalex +1 more source
Rheumatoid arthritis is a disease characterized by joint inflammation. Approximately 50% of patients show insufficient response to traditional synthetic disease‐modifying antirheumatic drugs. This study aims to elucidate differential molecular profiles of the mechanisms underlying drug responses through multi‐omics strategy.
Congcong Jian +26 more
wiley +1 more source
First-in-human evaluation of a no-alpha interleukin-2 mutein: safety and preliminary pharmacodynamic and clinical effect. [PDF]
Caballero Aguirrechu I +22 more
europepmc +1 more source
A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma [PDF]
F.Y. Ahmed +9 more
openalex +1 more source
This study investigates how ischemia‐free liver transplantation (IFLT) shapes both local and systemic immune responses compared with conventional liver transplantation (CLT). Our findings demonstrate that IFLT confers significant immunological protection by attenuating the STAT3‐HIF‐1α axis and enhancing the Heme‐HMOX1 pathway, two regulatory networks ...
Tao Luo +40 more
wiley +1 more source

